GSK Bangladesh chairman shares insights with The Daily Star Fifty countries are now listed as ‘least developed’. All these LDCs may not remain on the list in future. With time, many will graduate to upper-income levels, broadening prospects in many areas, including healthcare. GlaxoSmithKline (GSK), a leading pharmaceutical and healthcare company, looks to cash in ... Read more
glaxosmithkline
GSK to cut medicine prices
GlaxoSmithKline (GSK) is set to cut prices of a number of vaccine and pharmaceutical products marketed in Bangladesh by up to 61 percent, starting in August. The price cut is GSK’s Action for Access healthcare initiative to provide healthcare in the least develop countries within people’s ability to pay, said Duncan Learmouth, chairman of GSK ... Read more